Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron extract versus methylphenidate in attention deficit hyperactivity disorder
IRCT20101130005280N63Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron extract and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
saffron extractmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20101130005280N63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101130005280N63.